openPR Logo

Press Releases from DelveInsight Business Research LLP (5111 total)

Huntington's Disease Pipeline, FDA Approvals, Clinical Trials Development and Co …

DelveInsight's, "Huntington's Disease Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Huntington's Disease pipeline landscape. It covers the

Niemann-Pick-Disease Pipeline Outlook, Clinical Trials, FDA Approvals, and Compa …

DelveInsight's, "Niemann-Pick-Disease Pipeline Insight 2024" report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in the Niemann-Pick-Disease pipeline landscape. It covers the Niemann-Pick-Disease

Crohn's Disease Pipeline Outlook, FDA Approvals, Clinical Trials and Companies 2 …

DelveInsight's, "Crohn's Disease Pipeline Insight 2024" report provides comprehensive insights about 90+ companies and 90+ pipeline drugs in Crohn's Disease pipeline landscape. It covers the

Chronic Post-Amputation Pain Market, Trends, Outlook, Market Forecast 2032 | Med …

DelveInsight's "Chronic Post-Amputation Pain Market Insight & Forecast" report will offer an in-depth understanding of the Chronic Post-Amputation Pain market, further benefiting the competitors or

Ornithine Transcarbamylase Deficiency Market Trends, Outlook, Market Forecast 20 …

DelveInsight's "Ornithine Transcarbamylase Deficiency Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Ornithine Transcarbamylase Deficiency, historical and forecasted epidemiology as well

Fatty Acid Oxidation Disorders Market Trends, Outlook, Forecast 2032 | Ultrageny …

DelveInsight's "Fatty Acid Oxidation Disorders Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Fatty Acid Oxidation Disorders, historical and forecasted epidemiology

Cirrhosis Pipeline Outlook, FDA Approvals, Clinical Trials and Companies 2024 (U …

DelveInsight's, "Cirrhosis Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in the Cirrhosis pipeline landscape. It covers the Cirrhosis

Intraocular Lymphoma Market Trends, Outlook, Market Forecast 2032 | Celgene Corp …

DelveInsight's "Intraocular Lymphoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Intraocular Lymphoma, historical and forecasted epidemiology as well as the

Onycholysis Market Trends, Outlook and Market Forecast 2032 | Pfizer, Novartis, …

DelveInsight's "Onycholysis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Onycholysis, historical and forecasted epidemiology as well as the Onycholysis market

Alpha-1 Antitrypsin Deficiency Pipeline Outlook, Clinical Trials, FDA Approvals, …

DelveInsight's, "Alpha1-Antitrypsin Deficiency Pipeline Insight 2024" report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in the Alpha1-Antitrypsin Deficiency pipeline landscape. It covers

Constipation Pipeline, FDA Approvals, Clinical Trials Developments and Companies …

DelveInsight's, "Constipation Pipeline Insight 2024" report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in the Constipation pipeline landscape. It covers the Constipation

Myositis Pipeline Outlook, FDA Approvals, Clinical Trials and Companies 2024 (Up …

DelveInsight's, "Myositis Pipeline Insight 2024" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in the Myositis pipeline landscape. It covers the Myositis

Behçet's Disease Pipeline Outlook, FDA Approvals, Clinical Trials, and Companie …

DelveInsight's, "Behçet's Disease Pipeline Insight 2024" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Behçet's Disease pipeline landscape. It covers Behçet's

C-MET Non-Small Cell Lung Cancer Pipeline Outlook, Clinical Trials, FDA Approval …

DelveInsight's, "C-MET Non-Small Cell Lung Cancer (C-MET+ NSCLC) Pipeline Insight 2024" report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in the C-MET

Moderate to Severe Inflammatory Acne Vulgaris Pipeline Outlook, Clinical Trials, …

DelveInsight's, "Moderate to Severe Inflammatory Acne Vulgaris Pipeline Insight 2024" report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in the Moderate to

CRISPR Therapies Pipeline, FDA Approvals, Clinical Trials Developments and Compa …

DelveInsight's, "CRISPR Therapies Pipeline Insight 2024" report provides comprehensive insights about 25+ CRISPR Therapies Companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It

Cutaneous T-Cell Lymphoma Pipeline, FDA Approvals, Clinical Trials Developments …

DelveInsight's, "Cutaneous T-Cell Lymphoma Pipeline Insight 2024" report provides comprehensive insights about 30+ Cutaneous T-Cell Lymphoma Companies and 35+ pipeline drugs in the Cutaneous T-Cell

Chronic Myelomonocytic Leukaemia Pipeline, FDA Approvals, Clinical Trials Develo …

DelveInsight's, "Chronic Myelomonocytic Leukaemia Pipeline Insight" report provides comprehensive insights about 25+ Chronic Myelomonocytic Leukaemia companies and 25+ pipeline drugs in the Chronic Myelomonocytic Leukaemia

Adrenoleukodystrophy Pipeline Outlook, Clinical Trials, FDA Approvals, and Compa …

DelveInsight's, "Adrenoleukodystrophy Pipeline Insight 2024" report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in the Adrenoleukodystrophy pipeline landscape. It covers the Adrenoleukodystrophy

Methicillin Resistant Staphylococcus Aureus Pipeline Outlook, Clinical Trials An …

DelveInsight's, "Methicillin-Resistant Staphylococcus Aureus Infections Pipeline Insight 2024" report provides comprehensive insights about 25+ companies and 27+ pipeline drugs in Methicillin-Resistant Staphylococcus Aureus Infections pipeline

Nosocomial Pneumonia Pipeline, Clinical Trials, FDA Approvals, and Companies 202 …

DelveInsight's, "Nosocomial Pneumonia Pipeline Insight 2024" report provides comprehensive insights about 13+ companies and 13+ pipeline drugs in the Nosocomial Pneumonia pipeline landscape. It covers

Eosinophilic Esophagitis Pipeline, Clinical Trials, FDA Approvals, and Companies …

DelveInsight's, "Eosinophilic Esophagitis Pipeline Insight 2024" report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in the Eosinophilic Esophagitis pipeline landscape. It covers

Oral Mucositis Pipeline, FDA Approvals, Clinical Trials Developments and Compani …

(Albany, United States) As per DelveInsight's assessment, globally, the Oral Mucositis Pipeline constitutes 10+ Oral Mucositis companies continuously working towards developing 10+ Oral Mucositis Pipeline

Exosomes Pipeline Insights Report 2024 (Updated) | Capricor Therapeutics, Direct …

DelveInsight's, "Exosomes Pipeline Insight 2024" report provides comprehensive insights about 60+ companies and 110+ pipeline drugs in the Exosomes pipeline landscape. It covers the Exosomes

Obesity Pipeline Insights Report 2024 (Updated) | 180 Life Sciences, 9 meters, A …

DelveInsight's, "Obesity Pipeline Insight 2024" report provides comprehensive insights about 100+ companies and 130+ pipeline drugs in the Obesity pipeline landscape. It covers the Obesity

Type 2 Diabetes Pipeline Insights Report 2024 (Updated) | Hanmi Pharmaceuticals, …

DelveInsight's, "Type 2 Diabetes Mellitus Pipeline Insight 2024" report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Type 2 Diabetes mellitus pipeline

Metastatic Colorectal Cancer Pipeline Insights Report 2024 (Updated) | include M …

DelveInsight's, "Metastatic Colorectal Cancer Pipeline Insight 2024" report provides comprehensive insights about 130+ companies and 140+ pipeline drugs in the Metastatic Colorectal Cancer pipeline landscape.

Diabetes Pipeline Insights Report 2024 (Updated) | Daewoong Tradipitant, Janssen …

DelveInsight's, "Diabetes Pipeline Insights 2024" report provides comprehensive insights about 200+ companies and 200+ pipeline drugs in the Diabetes pipeline landscape. It covers the Diabetes

Ewing Sarcoma Pipeline, FDA Approvals, Clinical Trials, and Companies 2024 (Upda …

DelveInsight's, "Ewing Sarcoma Pipeline Insights 2024" report provides comprehensive insights about 25+ Ewing Sarcoma companies and 25+ pipeline drugs in the Ewing Sarcoma pipeline landscape.

Diffuse Intrinsic Pontine Glioma Pipeline, FDA Approvals, Clinical Trials, and C …

DelveInsight's, "Diffuse Intrinsic Pontine Glioma Pipeline Insight 2024" report provides comprehensive insights about 25+ Diffuse Intrinsic Pontine Glioma companies and 25+ pipeline drugs in the

Parkinson's Disease Pipeline, FDA Approvals, Clinical Trials and Companies 2024 …

DelveInsight's, "Parkinson's Disease Pipeline Insight 2024" report provides comprehensive insights about 140+ Parkinson's Disease companies and 150+ pipeline drugs in Parkinson's Disease pipeline landscape. It

Multiple Myeloma Pipeline, FDA Approvals, Clinical Trials, and Companies 2024 (U …

DelveInsight's, "Multiple Myeloma Pipeline Insights 2024" report provides comprehensive insights about 75+ Multiple Myeloma Companies and 80+ pipeline drugs in the Multiple Myeloma pipeline landscape.

Breast Cancer Pipeline, Clinical Trials, FDA Approvals, and Companies 2024 (Upda …

DelveInsight's, "Breast Cancer Pipeline Insight 2024" report provides comprehensive insights about 120+ Breast Cancer companies and 130+ pipeline drugs in the Breast Cancer pipeline landscape.

Acute Lymphocytic Leukemia Pipeline, Clinical Trials, FDA Approvals, and Compani …

DelveInsight's, "Acute Lymphocytic Leukemia Pipeline Insight 2024" report provides comprehensive insights about 150+ companies and 160+ pipeline drugs in the Acute Lymphocytic Leukemia pipeline landscape.

Non-Small Cell Lung Cancer Pipeline, Clinical Trials, FDA Approvals, and Compani …

DelveInsight's, Non-Small-Cell Lung cancer (NSCLC) Pipeline Insight, 2024," report provides comprehensive insights about 100+ companies and 120+ pipeline drugs in Non-Small-Cell Lung cancer (NSCLC) pipeline

Non-Hodgkin Lymphoma Pipeline, Clinical Trials, FDA Approvals and Companies 2024 …

DelveInsight's, "Non-Hodgkin Lymphoma Pipeline Insight 2024" report provides comprehensive insights about 200+ Non-Hodgkin Lymphoma companies and 220+ pipeline drugs in the Non-Hodgkin Lymphoma pipeline landscape.

Encephalopathy Pipeline, Clinical Trials, FDA Approvals, and Companies 2024 (Upd …

DelveInsight's, "Encephalopathy Pipeline Insight 2024" report provides comprehensive insights about 70+ Encephalopathy companies and 70+ pipeline drugs in the Encephalopathy pipeline landscape. It covers the

Cystic Fibrosis Pipeline, Clinical Trials, FDA Approvals, and Companies 2024 (Up …

DelveInsight's, "Cystic Fibrosis Pipeline Insight 2024" report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in the Cystic Fibrosis pipeline landscape. It covers

Postoperative Pain Market to Witness Growth by 2032 | Taiwan Liposome Company (T …

DelveInsight's "Postoperative Pain Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Postoperative Pain, historical and forecasted epidemiology as well as the

Obesity Market to Witness Growth by 2032, asserts DelveInsight | Novo Nordisk, E …

DelveInsight's "Obesity Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Obesity, historical and forecasted epidemiology as well as the Obesity market

Cardiac Arrhythmia Market to Rise by 2032, by DelveInsight | Applied Cardiac Sys …

DelveInsight's "Cardiac Arrythmia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Cardiac Arrythmia, historical and forecasted epidemiology as well as the

Retinal Vein Occlusion Market to Rise by 2032, asserts DelveInsight | AbbVie, Ro …

DelveInsight's "Retinal Vein Occlusion Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Retinal Vein Occlusion, historical and forecasted epidemiology as well

Hemodynamic Monitoring Systems Market to Showcase Robust Growth in the Upcoming …

In 2021, the Global Hemodynamic Monitoring Systems market reached a value of USD 982 million. It is projected to grow at a Compound Annual Growth

Coronary Stents Market to Showcase Robust Growth in the Upcoming Years | Major p …

The Global Coronary Stents Market was valued at USD 9.27 billion in 2021, growing at a CAGR of 7.51% during the forecast period from 2022

Chronic Gout Market to Show a Rise During the Study Period | Teijin Pharma, Hori …

DelveInsight's "Chronic Gout Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Chronic Gout, historical and forecasted epidemiology as well as the

Erosive Esophagitis Market to Show a Rise During the Study Period | Takeda Pharm …

DelveInsight's "Erosive Esophagitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Erosive Esophagitis, historical and forecasted epidemiology as well as the

Gestational Diabetes Market to Show a Rise During the Study Period | Braun, DexC …

DelveInsight's "Gestational Diabetes Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Gestational Diabetes, historical and forecasted epidemiology as well as the

Dysmenorrhea Market to Show a Rise During the Study Period | AbbVie, Neuroscienc …

DelveInsight's "Dysmenorrhea Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Dysmenorrhea, historical and forecasted epidemiology as well as the Dysmenorrhea market

Methylmalonic Acidemia Market to Show a Rise During the Study Period |Biosint S. …

Methylmalonic Acidemia Market to Show a Rise During the Study Period |Biosint S.p.A, Cayman Chemical, Ceva Sante Animale S.A, Chengda Pharmaceuticals Co.Ltd, DSM, Johnlee pharmaceuticals,

Pulmonary arterial hypertension Pipeline Outlook Report 2024 (Updated)

DelveInsight's, "Pulmonary Arterial Hypertension Pipeline Insight 2024," report provides comprehensive insights about 55+ companies and 55+ pipeline drugs in Pulmonary Arterial Hypertension pipeline landscape. It

Go To Page:    51 52 53 54 55 56 57 58 59 60